Burden of Disease of Multiple Sclerosis in Korea
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES: Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system. There are few reports on the burden of disease of MS, worldwide. The authors aim to estimate burden of disease and estimate the epidemiologic indexes of MS in Korea using available epidemiologic data. METHODS: Epidemiologic indexes were computed using DISMOD II software based on prevalence from nationwide survey, incidence estimated from extrapolation, mortality from National Statistics Office, and duration of disease from literature as input indexes. We calculated disability-adjusted life year (DALY) as a measure of premature mortality and disability, equivalent to years of healthy life lost due to a given condition. RESULTS: The incidence of MS in Korea was 0.1 per 100,000, higher in female than in male. The highest incidence was estimated in the age group between 35 and 44 years in male and age group between 25 and 29 years in female. Total burden of disease of MS was 1,394 DALY, comprised of 292 (21%) years of life lost and 1,101 (79%) years lived with disability. The mean age at onset of MS was 33 years old in men and 32 years old in female. Estimated duration of disease was 35 years in men and 40 years in female. Most of the DALY of MS occurred in the adult population between 25 and 54 years of age. CONCLUSION: Although MS is a rare disease in Korea, most of the DALY arises from young people, which results in a major financial burden on the patient, family, health system and society.
Abstract
OBJECTIVES: Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system. There are few reports on the burden of disease of MS, worldwide. The authors aim to estimate burden of disease and estimate the epidemiologic indexes of MS in Korea using available epidemiologic data. METHODS: Epidemiologic indexes were computed using DISMOD II software based on prevalence from nationwide survey, incidence estimated from extrapolation, mortality from National Statistics Office, and duration of disease from literature as input indexes. We calculated disability-adjusted life year (DALY) as a measure of premature mortality and disability, equivalent to years of healthy life lost due to a given condition. RESULTS: The incidence of MS in Korea was 0.1 per 100,000, higher in female than in male. The highest incidence was estimated in the age group between 35 and 44 years in male and age group between 25 and 29 years in female. Total burden of disease of MS was 1,394 DALY, comprised of 292 (21%) years of life lost and 1,101 (79%) years lived with disability. The mean age at onset of MS was 33 years old in men and 32 years old in female. Estimated duration of disease was 35 years in men and 40 years in female. Most of the DALY of MS occurred in the adult population between 25 and 54 years of age. CONCLUSION: Although MS is a rare disease in Korea, most of the DALY arises from young people, which results in a major financial burden on the patient, family, health system and society.
참고문헌 (36)
- Dean G, "How many people in the world have multiple sclerosis?", Neuroepidemiology, 13, pp.1~7 (1994)
- Poser CM, "The multiple sclerosis trait and the development of multiple sclerosis: genetic vulnerability and environmental effect", Clin Neurol Neurosurg, 108, pp.227~233 (2006)
- Weinshenker BG, "The natural history of multiple sclerosis: a geographically based study", I. Clinical course and disability. Brain, 112, pp.133~146 (1989)
- Compston A, "Multiple sclerosis", Lancet, 372, pp.1502~1517 (2008)
- Karampampa K, "Treatment experience, burden, and unmet needs in multiple sclerosis: the costs and utilities of MS patients in Canada", J Popul Ther Clin Pharmacol, 19, pp.11~25 (2012)
- Cheung YH, "Cost of illness and health: friendly fiscal policy", pp.102~119 (2009), Ministry of Health and Welfare
- Choi BH, "Strategy for the future development of national health insurance", pp.50~61 (2007), Ministry of Health and Welfare
- An HS, "A study on the selection criteria of rare disease support system", pp.45~76 (2007), Management Center for Health Promotion
- Risco J, "Latitudinal prevalence gradient of multiple sclerosis in Latin America", Mult Scler, 17, pp.1055~1059 (2011)
- Simpson S Jr, "Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis", J Neurol Neurosurg Psychiatry, 82, pp.1132~1141 (2011)
- Kim NH, "Prevalence of multiple sclerosis in Korea", NEUROLOGY, 75, pp.1432~1438, LIPPINCOTT WILLIAMS & WILKINS
- Kikuchi H, "Impact and characteristics of quality of life in Japanese patients with multiple sclerosis", Qual Life Res, 20, pp.119~131 (2011)
- Kira J, "Multiple sclerosis in the Japanese population", Lancet Neurol, 2, pp.117~127 (2003)
- Mathers C, "Boerma JT; World Health Organization, In The global burden of disease: 2004 update", pp.54~84 (2008), World Health Organization
- Yoon SJ, "Measuring the burden of major cancers due to premature death in Korea", Korean J Prev Med, 33, pp.231~238 (2000)
- 윤석준, "Measuring the burden of major cancers due to smoking in Korea", CANCER SCIENCE, 97, pp.530~534
- 오인환, "한국인의 질병부담", 대한의사협회지, 54(6), pp.646~652 (2011), 대한의사협회
- World Health Organization, "Neurological disorders: public health challenges", pp.27~37 (2006), World Health Organization
- Murray CJL, "Harvard School of Public Health; World Health Organization; World Bank, In The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020", pp.1~98 (1996), Harvard University Press
- Tator C, "The CBANCH report--the burden of neurological diseases, disorders, and injuries in Canada", Can J Neurol Sci, 34, pp.268~269 (2007)
- Torisu H, "Clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in Fukuoka Prefecture", Brain Dev, 32, pp.454~462 (2010)
- Granieri E, "Multiple sclerosis in the province of Ferrara: evidence for an increasing trend", J Neurol, 254, pp.1642~1648 (2007)
- Ekestern E, "Mortality from multiple sclerosis in Austria 1970-2001: dynamics, trends, and prospects", Eur J Neurol, 11, pp.511~520 (2004)
- "Population of Korea" (2012)[URL]
- Barendregt JJ, "A generic model for the assessment of disease epidemiology: the computational basis of DisMod II", Popul Health Metr, 1, pp.4~ (2003)
- "Global burden of migraine in the year 2000: summary of methods and data sources" (2012)[URL]
- Murray CJL, "Mortality by cause for eight regions of the world: Global Burden of Disease Study", Lancet, 349, pp.1269~1276 (1997)
- Pugliatti M, "The epidemiology of multiple sclerosis in Europe", Eur J Neurol, 13, pp.700~722 (2006)
- Ragonese P, "Multiple sclerosis survival: a population-based study in Sicily", Eur J Neurol, 17, pp.391~397 (2010)
- Ragonese P, "Mortality in multiple sclerosis: a review", Eur J Neurol, 15, pp.123~127 (2008)
- 이중규, "한국인 질병의 장애가중치 측정 및 신뢰도 평가", 예방의학회지, 36(2), pp.10~170 (2003), 대한예방의학회
- Seok-JunYoon, "Estimation of the Burden of Major Cancers in Korea", Journal of Korean Medical Science, 17(5), pp.604~610 (2002), 대한의학회
- Houzen H, "Increasing prevalence and incidence of multiple sclerosis in northern Japan", Mult Scler, 14, pp.887~892 (2008)
- Kingwell E, "Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada", J Neurol Neurosurg Psychiatry, 83, pp.61~66 (2012)
- Lalmohamed A, "Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort study", Eur J Neurol, 19, pp.1007~1014 (2012)
- Zhao BX, "Multiple sclerosis. A clinical study of 70 cases", Eur Neurol, 20, pp.394~400 (1981)